EUVIMEDEUVIMED entdecken
Crossref

Analytical method development and validation for simultaneous estimation of Bempedoic acid and Ezetimibe in pure and its pharmaceutical dosage form by RP‐HPLC

Aakash Suresh iD, Anbarasi Balakrishnan, Vijayamirtharaj Ramaswamy, Senthilkumar Natesan

Biomedical Chromatography · 2024

DOI: 10.1002/bmc.5938 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2024. Verfasst von Aakash Suresh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Analysis, JKKMMRFs-Annai JKK Sampoorani Ammal College of Pharmacy, The Tamil Nadu Dr. MGR Medical University, Namakkal, …. Hauptthemen laut MEDLINE: Ezetimibe, Chromatography, Reverse-Phase, Limit of Detection, Tablets. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: College of Pharmacy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A simple, accurate and precise method was developed for the simultaneous estimation of the bempedoic acid and ezetimibe in pure and tablet dosage form. The developed method was validated as per International Conference on Harmonization guidelines. The chromatographic separation was achieved isocratically on a Waters‐ C 18 , 250 × 4.6 mm, 5 μm column. Mobile phase containing K 2 HPO 4 –methanol in the ratio 60:40 in buffer at pH 4.3 was pumped through column at a flow rate of 1.0 ml/min. The temperature was maintained at 25°C. The optimized wavelength selected was 242 nm. The separation of bempedoic acid and ezetimibe showed retention times of 3.090 and 4.268 min respectively. The RSD values of the bempedoic acid and ezetimibe were 0.34 and 0.08 respectively. The accuracy of method was determined at three levels (50,100 and 150%). The percentage recovery was obtained as 100.0 and 100.0% for bempedoic acid and ezetimibe, respectively. The limits of determination and quantitation obtained from regression equations of bempedoic acid and ezetimibe were 1.065, 3.550 and 0.203, 0.677, respectively. The regression equation of bempedoic acid is y = 20,795 x + 24,168, and it is y = 6,885.7 x + 11,000 for ezetimibe. The retention times were decreased and the run time was decreased, so that the method developed is simple and economical that can be adopted for regular quality control tests in industry.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EzetimibeChromatography, Reverse-PhaseLimit of DetectionTabletsDicarboxylic AcidsFatty AcidsChromatography, High Pressure LiquidReproducibility of ResultsLinear Models

Stichwörter der Autor:innen

HPLCUV detectorbempedoic acidezetimibehyperlipidaemiamethod development and method Validation

Substanzen

EzetimibeTablets8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acidDicarboxylic AcidsFatty Acids

Autor:innen und Institutionen

  • Department of Pharmaceutical Analysis, JKKMMRFs-Annai JKK Sampoorani Ammal College of Pharmacy, The Tamil Nadu Dr. MGR Medical University, Namakkal, Tamil Nadu, India.

ORCID-Profile: Aakash Suresh

Förderung

  • College of Pharmacy

Zitieren

APA

Suresh, A., Balakrishnan, A., Ramaswamy, V., & Natesan, S. (2024). Analytical method development and validation for simultaneous estimation of Bempedoic acid and Ezetimibe in pure and its pharmaceutical dosage form by RP‐HPLC. Biomedical Chromatography. https://doi.org/10.1002/bmc.5938

Vancouver

Suresh A, Balakrishnan A, Ramaswamy V, Natesan S. Analytical method development and validation for simultaneous estimation of Bempedoic acid and Ezetimibe in pure and its pharmaceutical dosage form by RP‐HPLC. Biomedical Chromatography. 2024. doi:10.1002/bmc.5938

BibTeX
@article{Suresh2024,
  author = {Suresh, Aakash and Balakrishnan, Anbarasi and Ramaswamy, Vijayamirtharaj and Natesan, Senthilkumar},
  title = {Analytical method development and validation for simultaneous estimation of Bempedoic acid and Ezetimibe in pure and its pharmaceutical dosage form by RP‐HPLC},
  journal = {Biomedical Chromatography},
  year = {2024},
  doi = {10.1002/bmc.5938}
}
Kostenlos starten →